Loading…
IRADIMED CORPORATION is projected to rise to $121.77 by 2027, a +33% move from its current price of $91.84. IRMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $90.40 | $91.87 | $93.37 | +0.03% |
| May 30 | $89.82 | $91.90 | $94.03 | +0.07% |
| May 31 | $89.39 | $91.94 | $94.55 | +0.10% |
| Jun 1 | $89.04 | $91.97 | $94.99 | +0.14% |
| Jun 2 | $88.73 | $92.00 | $95.39 | +0.17% |
| Jun 3 | $88.46 | $92.03 | $95.75 | +0.21% |
| Jun 4 | $88.21 | $92.06 | $96.09 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $88.21 | $92.06 | $96.09 | +0.24% |
| Week 2 | $86.87 | $92.29 | $98.05 | +0.49% |
| Week 3 | $85.90 | $92.52 | $99.64 | +0.74% |
| Week 4 | $85.13 | $92.74 | $101.03 | +0.98% |
| Week 5 | $84.48 | $92.97 | $102.31 | +1.23% |
| Week 6 | $83.92 | $93.20 | $103.50 | +1.48% |
| Week 7 | $83.42 | $93.42 | $104.63 | +1.72% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IRADIMED CORPORATION is a healthcare company that develops, manufactures, markets, and distributes MRI compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories.
The product lines include the MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; the 3880 MRI compatible patient vital signs monitoring system; and the 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally.
IRADIMED was incorporated in 1992 and is headquartered in Orlando, Florida.
IRADIMED CORPORATION (IRMD) is currently trading at $92.10, with a market capitalization of $1.18B. It is ranked 2405.
Near-term outlook shows a 2026 forecast with a min of $83.44, an avg of $92.10, and a max of $130.74, with a neutral sentiment. The longer horizon is bullish from 2027 onward, with rising averages such as $123.94 in 2027, $155.54 in 2028, $167.01 in 2029, and $173.17 in 2030. By 2040 the avg is $464.44 and by 2050 it is $822.63, with max values reaching $236.58 in 2030, $709.25 in 2040, and $1,346.16 in 2050.
A major floor 13.6% below — a decisive break under it would weaken the trend.
The nearest floor, 9.1% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 14.5% above — clearing it would confirm fresh momentum.
Key IRMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IRMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $92.09 | Sell | $91.53 | Buy |
| MA 10 | $89.49 | Buy | $90.16 | Buy |
| MA 20 | $87.42 | Buy | $89.34 | Buy |
| MA 50 | $91.93 | Sell | $91.24 | Buy |
| MA 100 | $96.06 | Sell | $91.89 | Sell |
| MA 200 | $88.32 | Buy | $86.74 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.14 | Neutral |
| Stoch RSI (14) | 81.33 | Sell |
| CCI (20) | 120.61 | Buy |
| Williams %R (14) | -15.03 | Info |
| MACD (12,26,9) | 1.13 | Buy |
| ROC (12) | 6.44 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 84.97 | Sell |
| TRIX (15) | -0.17 | Sell |
| Awesome (5,34) | 3.08 | Buy |
| Ultimate (7,14,28) | 67.28 | Neutral |
| Momentum (10) | 7.09 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 93.84 | Sell |
| ADX (14) | 18.99 | Neutral |
| ATR (14) | 1.39 | Info |
The 30-day technical picture is bullish. RSI14 is 60. The 50-day moving average is $92.27 and the 200-day moving average is $88.09. Support is at $83.44 and resistance at $93.71. The 30-day trading range runs from $82.39 to $102.95.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $83.44 | $91.84 | $129.95 | 0% | Neutral | |
| $99.48 | $121.77 | $156.03 | +33% | Bullish | |
| $122.15 | $152.25 | $200.18 | +66% | Bullish | |
| $129.59 | $163.97 | $220.07 | +79% | Bullish | |
| $131.87 | $169.08 | $230.94 | +84% | Bullish | |
| $143.54 | $186.27 | $258.39 | +103% | Bullish | |
| $150.67 | $197.71 | $278.11 | +115% | Bullish | |
| $181.40 | $240.52 | $342.67 | +162% | Bullish | |
| $208.69 | $279.44 | $402.84 | +204% | Bullish | |
| $209.12 | $282.65 | $411.96 | +208% | Bullish | |
| $312.58 | $440.58 | $672.72 | +380% | Bullish | |
| $516.54 | $780.70 | $1,277.44 | +750% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $83.44 | $91.84 | $107.16 | +0.00% |
| June 2026 | $78.08 | $91.08 | $108.31 | -0.83% |
| July 2026 | $80.81 | $94.81 | $113.81 | +4.09% |
| August 2026 | $83.24 | $98.11 | $118.63 | +3.48% |
| September 2026 | $83.13 | $98.33 | $119.61 | +0.23% |
| October 2026 | $84.69 | $100.52 | $122.93 | +2.23% |
| November 2026 | $87.87 | $104.62 | $128.54 | +4.07% |
| December 2026 | $88.19 | $105.30 | $129.95 | +0.65% |
Click any year to see its month-by-month IRMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
IRADIMED CORPORATION's 2026 outlook centres on $91.84, within a $83.44 to $129.95 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, IRMD could reach as high as $156.03, with a base case around $121.77 and support toward $99.48 — roughly +33% from $91.84. Momentum favours further upside here.
Expect IRMD to range from $122.15 to $200.18 through 2028. The $152.25 average target implies a +66% move from current prices. That is up +25% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The IRMD price prediction for 2029 points to an average of $163.97 (low $129.59, high $220.07) — a potential gain of +79% on today's $91.84. Momentum favours further upside here.
In 2030, IRMD is projected to trade between $131.87 and $230.94, averaging $169.08 — a potential gain of +84% from today's $91.84. That is up +3% on the projected 2029 average. Buyers look set to stay in control over this stretch.
IRADIMED CORPORATION's 2031 outlook centres on $186.27, within a $143.54 to $258.39 range. That is up +10% on the projected 2030 average. That marks a +103% change versus current levels. Momentum favours further upside here.
By 2032, IRMD could reach as high as $278.11, with a base case around $197.71 and support toward $150.67 — roughly +115% from $91.84. Buyers look set to stay in control over this stretch.
Expect IRMD to range from $181.40 to $342.67 through 2033. The $240.52 average target implies a +162% move from current prices. That is up +22% on the projected 2032 average. Momentum favours further upside here.
The IRMD price prediction for 2034 points to an average of $279.44 (low $208.69, high $402.84) — a potential gain of +204% on today's $91.84. Buyers look set to stay in control over this stretch.
In 2035, IRMD is projected to trade between $209.12 and $411.96, averaging $282.65 — a potential gain of +208% from today's $91.84. That is up +1% on the projected 2034 average. Momentum favours further upside here.
IRADIMED CORPORATION's 2040 outlook centres on $440.58, within a $312.58 to $672.72 range. That is up +56% on the projected 2035 average. That marks a +380% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, IRMD could reach as high as $1,277.44, with a base case around $780.70 and support toward $516.54 — roughly +750% from $91.84. Momentum favours further upside here.
Investing $1,000 in IRMD today (≈ 10.888502 IRMD) could be worth
$8,500.69
+$7,500.69 (+750%) by 2050 · US Dollar
Based on the average projected IRMD price of $780.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IRMDwould be worth at today's price.
$1,000 invested in IRMD on May 27, 2025 (≈ 19.029496 IRMD) would be worth
$1,747.67
+$747.67 (+74.8%) today · 1.75× · US Dollar
Based on a IRMD entry price of $52.55 vs. today's $91.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $90.4 | $1,015.93 | +1.6% |
| 1 month ago | $89.08 | $1,030.98 | +3.1% |
| 3 months ago | $102.42 | $896.7 | -10.3% |
| 6 months ago | $93.22 | $985.2 | -1.5% |
| 1 year ago | $52.55 | $1,747.67 | +74.8% |
| All time (5.0y) ago | $28.5 | $3,222.46 | +222.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IRMD forecast.
Our base-case forecast reaches $180.00 around 2031.
Implied market cap at $180.00: $2.3B
The multi-year forecast shows a bullish trajectory with higher averages across the forecast horizon. From 2027 onward the asset is projected to rise, with 2027 avg $123.94 and 2028 avg $155.54, followed by 2029 avg $167.01 and 2030 avg $173.17. The forecast turns increasingly bullish, with 2031 avg $192.23, 2032 $204.18, 2033 $250.34, 2034 $290.85, and 2035 $292.52.
By 2040 the avg climbs to $464.44 and by 2050 to $822.63, while max values reach $236.58 in 2030, $709.25 in 2040, and $1,346.16 in 2050. The associated ROIs rise from 34.6% in 2027 to 88% in 2030, 404.3% in 2040, and 793.2% in 2050. These are forecasted estimates and not guaranteed, subject to market and company-specific risks.
Tap a question to reveal the answer.
2030 avg $173.17; min $135.03; max $236.58; ROI 88%.
Forecasts show NEUTRAL in 2026, then BULLISH from 2027 onward, with 2027 avg $123.94 (ROI 34.6%), 2030 avg $173.17 (ROI 88%), and 2050 avg $822.63 (ROI 793.2%).
Yes. The max forecasts exceed $200 in multiple years: 2028 max $204.57, 2029 max $224.22, 2030 max $236.58, 2031 max $266.71, and higher in later years.
Current price is $92.10; market cap is $1.18B.
Sentiment is BULLISH; RSI14 is 60; SMA50 is $92.27; SMA200 is $88.09; support is $83.44; resistance is $93.71; 30-day range is $82.39 to $102.95.
IRADIMED CORPORATION Community Discussion
0Share your IRADIMED CORPORATION price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.